As we approach the midpoint of July, it’s hard to believe how quickly time is flying by. With each passing…
Browsing: Obesity
Food Deserts and Their Impact on Health Outcomes: A Detailed Study For years, health experts have been raising concerns about…
Children who experience undernutrition may benefit from weight gain during their first decade of life, leading to taller adults without…
The obesity market is currently dominated by Novo Nordisk and Eli Lilly, the only companies with approved GLP-1s. However, with…
Credit: Unsplash/CC0 Public Domain As Australia faces a turning point in obesity management, researchers from Monash University have contributed new…
The Roche deal was a validation of Zealand’s approach to tackling obesity with novel peptide-based therapies. It showed that the…
Access to Weight Loss Drug Wegovy Still Limited Despite Medicaid Coverage in South Carolina CHARLESTON, S.C. — Page Campbell, a…
Novo Nordisk and Eli Lilly have established themselves as the market leaders in the obesity drug sector with their GLP-1…
Pfizer Halts Development of Obesity Pill Due to Liver Injury Concerns Pfizer has made the decision to discontinue the development…
Novo Nordisk Makes Bold Move in Obesity Market with New Triple Agonist Danish biopharma giant Novo Nordisk is making waves…
